4-methoxyamphetamine has been researched along with Aortic Valve Disease 1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Angelillis, M; Casassus, F; De Backer, O; De Biase, C; Dumonteil, N; Hovasse, T; Kardys, I; Leroux, L; Modine, T; Mylotte, D; Nolasco, T; Petronio, AS; Piazza, N; Saint-Etienne, C; Siddiqui, S; Sondergaard, L; Souteyrand, G; Sudre, A; Tchétché, D; Teiger, E; Teles, RC; Van Mieghem, NM; Ziviello, F | 1 |
1 other study(ies) available for 4-methoxyamphetamine and Aortic Valve Disease 1
Article | Year |
---|---|
Transcatheter aortic valve implantation with the Evolut platform for bicuspid aortic valve stenosis: the international, multicentre, prospective BIVOLUTX registry.
Topics: Aortic Valve; Aortic Valve Stenosis; Bicuspid Aortic Valve Disease; Constriction, Pathologic; Death; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Mitral Valve Stenosis; Prospective Studies; Prosthesis Design; Registries; Transcatheter Aortic Valve Replacement; Treatment Outcome | 2023 |